<DOC>
	<DOCNO>NCT01101919</DOCNO>
	<brief_summary>This study design evaluate level CP-690,550 blood healthy Chinese subject follow single dos multiple dos drug .</brief_summary>
	<brief_title>CP-690,550 Pharmacokinetics In Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Healthy Chinese Volunteers No evidence active latent inadequately treated infection Mycobacterium tuberculosis ( TB ) Clinically significant infection within past 3 month Positive screen test hepatitis B surface antigen , antihepatitis C antibody , human immunodeficiency virus Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>